Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU ยท Real-Time Price ยท USD
2.660
0.00 (0.00%)
At close: Nov 20, 2026, 4:00 PM EST
2.650
-0.010 (-0.38%)
After-hours: Nov 20, 2026, 7:55 PM EST
Aytu BioPharma Employees
As of June 30, 2026, Aytu BioPharma had 76 total employees, including 75 full-time and 1 part-time employees. The number of employees decreased by 7 or 8.43% compared to the previous year. That makes Aytu BioPharma the 33,048th largest employer in the world and 4,286th in the United States.
Employees
76
Change (1Y)
-7
Growth (1Y)
-8.43%
Revenue / Employee
$770,053
Profits / Employee
-$264,447
Market Cap
28.91M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 76 | -7 | -8.43% | 75 | 1 |
| Jun 30, 2025 | 83 | -16 | -16.16% | 82 | 1 |
| Jun 30, 2024 | 99 | -51 | -34.00% | 99 | 0 |
| Jun 30, 2023 | 150 | -14 | -8.54% | 150 | 0 |
| Jun 30, 2022 | 164 | -11 | -6.29% | 164 | 0 |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 285 |
| Zhengye Biotechnology Holding | 269 |
| China Pharma Holdings | 215 |
| Rockwell Medical | 157 |
| SCYNEXIS | 18 |
| Incannex Healthcare | 12 |
| Talphera | 12 |
| Shuttle Pharmaceuticals Holdings | 2 |
AYTU News
- 3 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Aytu BioPharma, Inc. (Nasdaq โ AYTU), Rapid Micro Biosystems, Inc. (Nasdaq โ RPID), Advantage Energy Ltd. (OTC โ AAVVF), Canaccord Genuity Group Inc. (OTC โ CCORF) - GlobeNewsWire
- 3 days ago - Aytu BioPharma downgraded to Hold from Buy at Maxim - TheFly
- 4 days ago - Aytu BioPharma downgraded to Hold from Buy at Lake Street - TheFly
- 4 days ago - Aytu BioPharma reports Q1 EPS (20c), consensus (18c) - TheFly
- 4 days ago - AYTU BioPharma trading resumes - TheFly
- 4 days ago - Aytu BioPharma to be acquired by Rosemont Pharmaceuticals for $2.70 per share - TheFly
- 4 days ago - Aytu BioPharma Earnings release: Q1 2027 - Filings
- 4 days ago - Aytu BioPharma Quarterly report: Q1 2027 - Filings